The Prostate Specific G-Antigen Receptor (PSGR) is a member of the G protein-coupled receptor (GPCR) family that is predominantly expressed in the olfactory epithelium and has been the subject of research due to its potential involvement in the detection of semiochemicals. Although the name suggests specificity to the prostate, PSGR's expression is not confined to this gland, and it has been observed in other tissues as well. Understanding the regulation of PSGR expression is of significant interest in the scientific community, as this receptor plays a role in cell signaling processes that are fundamental to cellular communication and function. Research into PSGR and its regulation is ongoing, and the mechanisms by which its expression is controlled are complex and multifaceted, involving a variety of signaling pathways and molecular interactions.
A range of specific chemical compounds has been identified that may play a role in influencing the expression of PSGR. These activators are not peptides, proteins, or antibodies but include several small molecules that interact with intracellular signaling cascades, potentially leading to the upregulation of PSGR. Compounds such as forskolin, which increases cAMP levels, and retinoic acid, a ligand for nuclear hormone receptors, have been speculated to stimulate PSGR expression through their respective cellular signaling pathways. Other molecules, like dexamethasone and β-estradiol, may interact with nuclear hormone receptors to initiate transcriptional events that increase PSGR expression. Moreover, epigenetic modifiers such as sodium butyrate and trichostatin A, which alter chromatin structure, could also play a role in enhancing the transcription of the PSGR gene. Additionally, molecules like capsaicin, which activates sensory neuron receptors, may indirectly lead to increased PSGR expression through their effects on cellular signaling networks. While the precise mechanisms by which these compounds induce PSGR expression remain to be elucidated, research suggests that their influence on various signaling pathways and transcriptional processes could be the key to understanding PSGR regulation.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin can elevate intracellular cAMP, which may lead to the activation of cAMP response element-binding protein (CREB). CREB, in turn, could stimulate the transcription of a range of GPCRs, potentially including PSGR. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid serves as a ligand for nuclear receptors that control the transcription of genes. This compound could upregulate PSGR by binding to its receptor, initiating transcriptional processes that increase PSGR mRNA levels. | ||||||
Diethylstilbestrol | 56-53-1 | sc-204720 sc-204720A sc-204720B sc-204720C sc-204720D | 1 g 5 g 25 g 50 g 100 g | $70.00 $281.00 $536.00 $1076.00 $2142.00 | 3 | |
Diethylstilbestrol, as a synthetic analog of estrogen, could upregulate PSGR expression by engaging with estrogen receptors that can induce transcriptional changes in GPCR gene expression within hormone-sensitive tissues. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone, through its action as a glucocorticoid, can bind to glucocorticoid receptors, which may result in increased transcription of certain GPCRs. This could theoretically include upregulation of PSGR in responsive cell types. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride has been shown to stimulate the Wnt signaling pathway, which is implicated in the transcriptional control of numerous genes. Through this pathway, lithium may induce the expression of various GPCRs, possibly PSGR. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 18 | |
Sodium butyrate, through its inhibition of histone deacetylases, can increase histone acetylation leading to a more open chromatin structure and potentially the upregulation of GPCR genes, including PSGR. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
β-estradiol may engage estrogen receptors, leading to the transcriptional activation of target genes. Its role in the reproductive system suggests it could stimulate PSGR expression in estrogen-responsive cells. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, by inhibiting histone deacetylases, can result in enhanced acetylation of histones, thereby permitting transcription factors to access DNA more easily and possibly induce PSGR gene expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin Gallate, a polyphenol, may upregulate detoxifying enzymes' genes and could extend its gene-inducing capabilities to GPCRs like PSGR through antioxidant response elements. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin can activate transcription factors such as nuclear factor-kappa B (NF-κB), which might increase the expression of genes including those coding for GPCRs, hence potentially stimulating PSGR expression. |